Variant report
Variant | esv3417547 |
---|---|
Chromosome Location | chr8:67162648-67164946 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs546539163 | chr8:67162653-67162654 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
2 | rs556857898 | chr8:67162733-67162734 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
3 | rs35632247 | chr8:67162767-67162768 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
4 | rs377419298 | chr8:67162768-67162769 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
5 | rs59602598 | chr8:67162786-67162787 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
6 | rs12335081 | chr8:67162849-67162850 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
7 | rs184024213 | chr8:67162870-67162871 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
8 | rs373081795 | chr8:67162894-67162895 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
9 | rs563211307 | chr8:67162950-67162951 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
10 | rs530511592 | chr8:67162977-67162978 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
11 | rs186871456 | chr8:67163023-67163024 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
12 | rs550644583 | chr8:67163037-67163038 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
13 | rs147881820 | chr8:67163067-67163068 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
14 | rs115334565 | chr8:67163113-67163114 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
15 | rs546740842 | chr8:67163203-67163204 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
16 | rs72650583 | chr8:67163272-67163273 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
17 | rs369672973 | chr8:67163274-67163275 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
18 | rs200901830 | chr8:67163323-67163324 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
19 | rs13282495 | chr8:67163373-67163374 | Weak transcription ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs555232916 | chr8:67163385-67163386 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
21 | rs191232287 | chr8:67163389-67163390 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
22 | rs185713681 | chr8:67163453-67163454 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs201338495 | chr8:67163470-67163471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs376545163 | chr8:67163705-67163706 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs190535817 | chr8:67163726-67163727 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs578018608 | chr8:67163814-67163815 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs2469255 | chr8:67163816-67163817 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs7836590 | chr8:67163818-67163819 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs141504323 | chr8:67163820-67163821 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs575333981 | chr8:67163822-67163823 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs563175081 | chr8:67163876-67163877 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs532050418 | chr8:67163968-67163969 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs117613037 | chr8:67163982-67163983 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs150168313 | chr8:67164037-67164038 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs138643296 | chr8:67164061-67164062 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs75790481 | chr8:67164062-67164063 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544182197 | chr8:67164095-67164096 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs563982483 | chr8:67164127-67164128 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs182396146 | chr8:67164215-67164216 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs529073673 | chr8:67164216-67164217 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs2446444 | chr8:67164217-67164218 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs115393716 | chr8:67164234-67164235 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs372492913 | chr8:67164244-67164245 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs557700206 | chr8:67164277-67164278 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs571527725 | chr8:67164284-67164285 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs534231866 | chr8:67164285-67164286 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs188885330 | chr8:67164296-67164297 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs181254226 | chr8:67164320-67164321 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs574126861 | chr8:67164350-67164351 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs376054485 | chr8:67164398-67164399 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Sezary syndrome | 18413736 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:67161200-67163000 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr8:67162200-67163200 | ZNF genes & repeats | iPS-20b Cell Line | embryonic stem cell |
3 | chr8:67162200-67163400 | ZNF genes & repeats | HUES64 Cell Line | embryonic stem cell |
4 | chr8:67162400-67162800 | ZNF genes & repeats | iPS-15b Cell Line | embryonic stem cell |
5 | chr8:67162600-67163000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr8:67162600-67164200 | Weak transcription | H1 Cell Line | embryonic stem cell |
7 | chr8:67162600-67164600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr8:67162800-67164000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
9 | chr8:67163200-67164000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
10 | chr8:67163400-67164000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
11 | chr8:67163800-67164400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr8:67164000-67164200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
13 | chr8:67164000-67164600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
14 | chr8:67164000-67164800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
15 | chr8:67164000-67165200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr8:67164000-67166200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
17 | chr8:67164200-67164400 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
18 | chr8:67164200-67164600 | Flanking Active TSS | HUES64 Cell Line | embryonic stem cell |
19 | chr8:67164200-67165400 | Enhancers | H1 Cell Line | embryonic stem cell |
20 | chr8:67164200-67165400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
21 | chr8:67164400-67165200 | Flanking Active TSS | iPS-18 Cell Line | embryonic stem cell |
22 | chr8:67164600-67165000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
23 | chr8:67164600-67165600 | Enhancers | HepG2 | liver |
24 | chr8:67164800-67165200 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |